European Urology

Viewing slides 1-6 of 7

• S0302-2838(12)00010-3.title drag remove slide sort drag into slide Title The Impact of Interscreening Interval and Age on Prostate Cancer Screening With Prostate-Specific Antigen
  
  Grace Hui-Min Wu, Anssi Auvinen, Amy Ming-Fang Yen, Matti Hakama, Teuvo L. Tammela, ... The Impact of Interscreening Interval and Age on Prostate Cancer Screening With Prostate-Specific ... Zoom
• S0302-2838(12)00010-3.introduction drag remove slide sort drag into slide Introduction • Population-based screening for prostate cancer (PCa) using serum prostate-specific antigen (PSA) has been adopted since the early 1990s.
  
  • Screening efficacy could be affected by ... • Population-based screening for prostate cancer (PCa) using serum prostate-specific antigen ... Zoom
• 20307 drag remove slide sort drag into slide Decision analysis framework for prostate-specific antigen (PSA) screening. CNa ... Zoom read this article »
• 20309 drag remove slide sort drag into slide The natural history of prostate cancer (PCa) taking other causes of death into ... Zoom read this article »
• S0302-2838(12)00010-3.materials_and_methods drag remove slide sort drag into slide Materials and methods • Parameters pertaining to the natural history of PCa and sensitivity were estimated using data from the Finnish quadrennial screening program:
  
  • starting at 55 yr of age and ... • Parameters pertaining to the natural history of PCa and sensitivity were estimated using ... Zoom
• S0302-2838(12)00010-3.results drag remove slide sort drag into slide Results • With 65% attendance and 20% contamination, screening would result in an 11.1% reduction in advanced cancers and a 7.3% reduction in PCa death, with corresponding absolute risk difference of ... • With 65% attendance and 20% contamination, screening would result in an 11.1% reduction in ... Zoom

Viewing slides 1-6 of 7